IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

Shasun gains FDA and Brazilian Anvisa approvals for Puducherry plant

12:10 PM MDT | July 17, 2013 | Natasha Alperowicz

Shasun Pharmaceuticals (Chennai, India), a leading producer of active pharmaceutical ingredients and formulations catering for global customers, says it completed the US FDA inspection during the last week in June to gain approval for certain products that have been commercially launched by its undisclosed customer in the United States. The inspection concluded that the facility, systems, and practices comply with FDA requirements. Shasun tells CW that the plant is based at Puducherry and is a formulation facility.   The plant has also undergone a Brazilian...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers

 

 

 













 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2012 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa